•  
  •  
  •  
  •  

2026-04-18 00:13:25

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Hathway Cable and Datacom Limited Announces Audited Financial Results for FY 2025-26
  • Jio Financial Services Limited Reports Strong Revenue Growth for FY 2025-26
  • Mastek Limited Reports Robust Revenue Growth and Enhanced Profitability for FY 2025-26
  • Bajaj Consumer Care Limited Reports 52% Surge in Annual Net Profit for FY 2025-26
  • National Standard (India) Limited Announces FY 2025-26 Financial Results

Keywords Selected:  Inspection

Stock Report

  • USFDA inspection at Cipla Ltd's manufacturing facility in Goa, India
  • Morepen Secures Fourth Consecutive USFDA Inspection with Zero Observations
  • Granules Life Sciences Receives VAI Classification following US FDA Inspection
  • Completion of US-FDA Inspection at Unit-IV, Tarapur of Aarti Pharmalabs Limited
  • Unit-IV of APL Healthcare Ltd classified as VAI by the US FDA
  • Completion of US FDA Inspection at Unit I of Eugia Pharma Specialities Ltd., Shameerpet
  • Closure of USFDA inspection at Zydus' Injectable plant at Ahmedabad
  • Alembic Pharmaceuticals Ltd receives 2 observations for Karakhadi Injectable Facility
  • USFDA inspection at the manufacturing facility of Enzene Biosciences Limited
  • Strides Pharma Inc's Chestnut Ridge facility gets 4 observations from USFDA
  • US FDA determines Sun Pharma's Baska facility inspection classification as OAI
  • Successful completion of USFDA inspection at Vizag facility
  • Caplin Point Laboratories Ltd's injectables facility completes INVIMA audit successfully
  • Apitoria Pharma Pvt Ltd receives 3 observations from USFDA for Unit-V
  • GMP Inspection by Malta Medicines Authority at Alkem's manufacturing facility located at Daman, India
  • Ipca Laboratories Ltd receives 3 observations from USFDA for API facility at Tarapur
  • Granules India's Packaging Facility in US Completes FDA inspection with Zero Observations
  • Glenmark Pharmaceuticals Ltd update on USFDA PAI at Chhatrapati Sambhajinagar Facility
  • Innoxel Lifesciences Successfully Completes EU GMP Inspection by Belgium's FAMHP
  • GMP Inspection by Ministry of Health, Armenia at Alkem's manufacturing facility located at Sikkim, India
  • Shilpa Medicare Ltd receives 8 observations from USFDA for Unit 4 at Jadcherla
  • Lupin Ltd receives 7 observations from USFDA for Goa manufacturing facility
  • NATCO Pharma Ltd receives 7 Observations from USFDA for API unit at Manali, Chennai
  • Solara announces successful closure of US FDA inspection of its Mangalore Facility with continued state of compliance on cGMP

Latest Post

  • Hathway Cable and Datacom Limited Announces Audited Financial Results for FY 2025-26
  • Jio Financial Services Limited Reports Strong Revenue Growth for FY 2025-26
  • Mastek Limited Reports Robust Revenue Growth and Enhanced Profitability for FY 2025-26
  • Bajaj Consumer Care Limited Reports 52% Surge in Annual Net Profit for FY 2025-26
  • National Standard (India) Limited Announces FY 2025-26 Financial Results


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025